Abstract
Atherosclerosis develops as a consequence of inflammation and cell senescence. In critical factors involved in the atherosclerotic changes, reactive oxygen species (ROS) generation is considered a leading cause. While NADPH oxidases, particularly NOX2, are the main sources of ROS, how they are regulated in the disease is incompletely understood. In addition, how caveolae, the membrane structure implicated in oxLDL deposition under vascular endothelia, is involved in the oxLDL-mediated ROS production remains mostly elusive. We report here that macrophages exposed to oxLDL up-regulate its caveolin-1 expression, and the latter in turn up-regulates NOX2 p47phox level. This combination effect results in increased cellular senescence. Interestingly, oxLDL treatment causes the p47phox residing in the cytosol to translocate to the caveolae. Immunoprecipitation assays confirms that cavelin-1 is in high degree association with p47phox. These results suggest caveolin-1 may serve as the membrane target for p47phox and as a switch for ROS production following oxLDL exposure. Our results reveal a previously unknown molecular event in oxLDL-mediated cellular ageing, and may provide a target for clinical intervention for atherosclerosis.
Keywords: atherosclerosis, cell senescence, caveolin-1, p47phox
Introduction
Atherosclerosis is a disease of ageing and inflammation. It is a pathological consequence of vascular plaque formation. At late stages, a fraction of plaques rupture, leading to thrombosis, the clinical manifestation of cardiovascular pathologies. The plaque formation is complex, driven by local lesion, inflammatory milieu, cholesterol deposition, and other factors [1]. In this process, reactive oxygen species (ROS) are involved in at multiple stages of pathogenesis [2,3].
Amongst many sources of ROS, NADPH oxidase is relatively well-characterized [4]. The dominant vascular NADPH oxidase isoform is NOX2 [5]. NOX2 has several subunits. Gp91 (CYBB, mediating the electron transfer in the oxidase) and gp22 (CYBA) are membrane-bound and collectively form cytochrome b558. The regulatory subunits p47phox, p67phox, p40phox, and a GTPase remain in the cytosol until activation. Activation signals can turn on NOX2, via extensive phosphorylation of p47phox. In the resting cells, p47phox is in a state of auto-inhibition. Its tandem SH3 domains bind to its own C-terminal polybasic region (PBR) sequence [5]. A diverse collection of stimulations lead to p47 phosphorylation at several residues, leading to its structural opening. The sites of phosphorylation often reflect the nature of distinct stimulation and likely to fine-tune the consequences. Following the phosphorylation, the cytosolic subunits then move to the membrane to form the functional cytochrome b558.
Regarding the membrane structures that are involved in atherosclerosis, one of the most studied is caveolae [6–8]. They are 50–100 nm membrane structures that have been regarded as one of the subset of lipid rafts due to their morphology and lipid composition [9]. Upon stimulation, they may form flask-like invagination into the cell and become internalized. Distinct from conventional endophagosomes, there is little evidence that caveolae internalization is associated with endosome/lysosome formation. Rather they appear to be a transport system that deliver its cargos to the endocytic system [10]. With regard to atherosclerosis, the caveolae system has been implicated in transporting LDL to cross the epithelial cells and in the deposition of cholesterol in vascular walls [11–13]. However, mounting evidence suggests that caveolae is involved in signal transduction. The structural formation of caveolae is dependent on caveolin-1 expression which forms the scaffold to support the flask-like membrane indentation. However, an interesting property of caveolin-1 is its ability to interact with a large number of proteins and lipid species [14]. Caveolin-1 has an internal sequence that is buried in the inner leaflet with both N- and C-termini free in the cytosol. A caveolin scaffolding domain (CSD) is involved in multiple protein bindings, such as src family kinases, MAPKs and NO synthases, and those bindings can result in both activation and inhibition [15,16].
As both NOX2 and caveolin-1 are involved in senescence, it is an interesting study how p47phox and caveolin-1 interact with each other in the ageing process, particularly in atherosclerosis. In this brief report, we demonstrate that two events are at the center of oxLDL-mediated ageing. We first show that oxLDL mediates caveolin-1 and p47phox expression in a chain event whereby the absence of caveolin-1 leads to diminished p47phox protein expression. The caveolin-1 expression is associated with increased oxidative response and cellular senescence. Depletion of caveolin-1 blocks these events. Second, we show that upon oxLDL stimulation, caveolin-1 is in physical association with p47phox and ROS production appears to be confined in caveolae. These findings reveal new details how oxLDL may contribute to atherosclerotic pathology and may suggest new targets of clinical intervention.
Materials and methods
Cell culture
RAW264.7 cells were cultured in RPMI-1640 medium (HyClone, America) supplemented with 10% FBS (Gibco, America), 100 U/ml penicillin and 100 mg/ml streptomycin, 10 mM HEPES and 50 μM β-mercaptoethanol. HEK293T cells were maintained in DMEM supplemented with 10% FBS and the antibiotics described above. For the experiment, cells were growth arrested in serum-free medium for 12 h. To verify the changes of caveolin-1 in senescent cells, RAW264.7 were incubated with different concentrations of oxLDL (0–80 μg/ml) for 24 h or with different times. To explore the underlying mechanisms of caveolin-1 in senescent cells, ctrl shRNA or cav1 shRNA transfected Raw264.7 cells were treated with oxLDL or left untreated.
Knockdown of gene expression using shRNA
Five shRNA clone targetting Cav1 were purchased from Sigma: F11 CCGGCCAGTTAGATTTAGGGATTTACTCGAGTAAATCCCTAAATCTAACTGGTTTTTG; F12CCGGCCGCTTGTTGTCTACGATCTTCTCGAGAAGATCGTAGACAACAAGCGGTTTTTG; G1 CCGGCGACGTGGTCAAGATTGACTTCTCGAGAAGTCAATCTTGACCACGTCGTTTTTG; G2 CCGGTGAAGCTATTGGCAAGATATTCTCGAGAATATCTTGCCAATAGCTTCATTTTTG; G3 CCGGGCTTCCTGATTGAGATTCAGTCTCGAGACTGAATCTCAATCAGGAAGCTTTTTG.
Lentiviral particles were packaged in 293FT using Lipofectamine 2000 reagent (Invitrogen, America). shRNA plasmid was transfected with the packing plasmid pCMVΔ8.9 and the envelope plasmid pHCMV-G. Scrambled shRNA was used as a control. Forty-eight hours later, supernatant containing viral particles was collected with 2000 rpm centrifugation for 5 min at 4°C. Raw264.7 cells were seeded at 5 × 105 per well in six-well plates (approximately 70% confluent). After 12 h, 0.5 ml culture supernatant containing the lentivirus was added to the wells in the presence of 8 μg/ml Polybrene. The plates then were centrifuged at 2500 rpm at 32°C for 1 h and returned to the culture. Twenty-four hours later, fresh medium containing 3 μg/ml puromycin was added to the plates for selection and the puromycin medium was changed every other day. Stable shRNA expressing cell line was selected by 7 days. The caveolin-1 mRNA level in different shRNA transfected groups was examined by RT-PCR.
RNA analysis
Total RNA was isolated from RAW264.7 using Takara TRIzol reagent. Reverse transcription was performed with Takara PrimeScript RT kit with gDNA Eraser. It was followed by RT-PCR analysis. Amplification primers for caveolin-1 are as follows: F CTACAAGCCCAACAACAAGGC and R AGGAAGCTCTTGATGCACGGT. RT-PCR analysis for β-actin was carried out using Forward CTGGACTTCGAGCAAGAGATG and Reverse TGATGGAGTTGAAGGTAGTTTCG primer pairs. The RT-PCR was performed on Bio-Rad C1000 Touch™ Thermal Cycler using SYBR green mix (Genestar) according to manufacturer’s instructions.
Western blotting
For caveolin-1 and p47phox protein detection, the cells were lysed in the lysis buffer (50 mM Tris/HCl, pH 7.4, 0.1 mM EDTA, and protease-inhibitor mixture) and the membrane fraction of cell lysate was prepared by ultracentrifugation (100000×g for 1 h at 4°C). Protein concentration was quantitated with BCA protein quantity assay kit (Applygen, Beijing, China). Equal amounts of proteins were loaded on to SDS/polyacrylamide gel (10 or 12% gel), separated by electrophoresis and transferred on to PVDF membranes. After blocking with 5% skim milk in TBS with 0.05% Tween 20 (TBS-T) for 1 h at room temperature, membranes were incubated with mouse anti-p47phox (1:1000), rabbit anti-caveolin-1 (1:1000), rabbit anti-actin (1:1500), mouse anti-GAPDH (1:1500), overnight at 4°C. All primary antibodies were from Santa Cruz Biotchnology except for the last one from BioLegend. Membranes were washed three times in TBS-T for 10 min and incubated with HRP-labeled second antibodies (1:8000) for 1 h at room temperature, the bands of interest were detected using an enhanced chemiluminescent stain.
Senescence assay
A commercial kit for β-galactosidase (β-gal) staining was used to assess the RAW264.7 senescence induced by ox-LDL (Beyotime Biotechnology, China). For cell senescence assay, ctrl shRNA or caveolin-1 shRNA transfected Raw264.7 cells were treated with oxLDL or left untreated. Twenty-four hours later, cells were washed three times with PBS when grown up to 80% confluence. The fixation solution which included 2% formaldehyde, 0.2% glutaraldehyde was added to cells at room temperature. After 5 min, cells were washed three times with PBS. Then, freshly prepared 1 ml SA-β-gal was used to stain the cells at 37°C for 12–16 h. The blue precipitates can be seen in the cytoplasm. For each sample, six fields were randomly selected. The percentage of positive cells was calculated.
ROS measurement
The level of intracellular ROS generation was determined by measuring the oxidative conversion of DCFH-DA (Sigma) to fluorescent dichlorofluorescin (DCF). Briefly, RAW264.7 (5 × 105 cells) were treated with 60 μg/ml oxLDL for 6 h while ROS inducer was used as the positive control. Cells were digested by 0.25% trypsin (Invitrogen) with 0.01% EDTA and terminated by medium containing 10% FBS. Cells were washed three times with PBS, and fluorescent intensity was measured by FBS. Mean fluorescence intensity (MFI) was used to indicate the ROS level.
Gelatin zymography
For gelatin zymography assay, cell supernatants were quantitated by Bio-Rad reagent for protein concentration and 30 μg protein was loaded into SDS/PAGE (10% gel) supplemented with 1% gelatin. After electrophoresis, gels were washed twice for 30 min at room temperature in 2.5% Triton X-100 to remove the SDS. Then, gels were stained with 0.05% Coomassie Brilliant Blue R250 in 30% methanol and 10% acetic acid at 37°C for 3 h, then the gels were incubated with destaining buffer until bands can clearly be seen. Finally, gels were scanned by digital gel imaging system.
Co-immunoprecipitation
For immunoprecipitation assay, ctrl shRNA or caveolin-1 shRNA transfected RAW264.7 cells were treated with oxLDL or left untreated. Four hours later, cells were lysed with NP-40 lysis buffer (50 mM HEPES pH 7.4, 150 mM NaCl, 1% NP-40, 1 mM EDTA, 1 mM PMSF, 1 mM NaF, 1 mM NaVO3, and protease inhibitor cocktails). The cell lysates were incubated with antibody–bead mixtures overnight at 4°C. Beads were then collected by low speed centrifugation (10000×g, 5 min) and washed four times with immunoprecipitation lysis buffer (300 mM NaCl added). Pellets were then subjected to the Western blotting analyses.
Fluorescent imaging
For immune fluorescent staining, cells were washed three times with cold PBS and fixed with 4% paraformaldehyde for 20 min at room temperature. Then, cells were washed three times with PBS and permeabilized with 0.2% Triton X-100 in PBS for 30 min. After permeabilization, cells were washed three times with PBS and blocked by adding house serum during 30 min at room temperature. Then samples were stained with anti-p47phox and anti-caveolin-1 antibodies, washed with PBS for three times, incubated with the second antibodies and washed subsequently. Finally, samples were mounted and observed under a confocal laser-scanning microscope.
Statistics
All results were presented as means ± S.D. Statistical differences amongst groups were assessed using ANOVA. Post hoc comparisons were performed with Tukey’s test to indicate the significant variations between groups. A value of P<0.05 was considered to be statistically significant.
Results
oxLDL promotes caveolin-1 production
In our previous analysis of eNOS regulation, we found that in addition to its well-characterized targetting to caveolin-1, the eNOS also blocked caveolin-1 production [17]. As eNOS is a key regulator of epithelial homeostasis, we wondered if the previous results implied that caveolin-1 level served as a balance control in oxidase responses. Using RAW264.7 as the model, we stimulated these cells with increasing amounts of oxLDL (Figure 1A,B). oxLDL treatment substantially increased the abundancy of caveolin-1 at the protein and mRNA levels in a dose–response manner from 20 to 80 μg/ml. Using a dose of 60 μg/ml, oxLDL stimulated the increase after 24 h, although the mRNA increase was seen after 12 h. Previously, it was reported that this increase was driven by ERK and MAPK expression [18], however how this up-regulation is related to downstream inflammatory consequences was not well understood. To that end, we produced a series of shRNA and tested their knockdown efficiency. Amongst them a particular construct reduced caveolin-1 expression levels (Figure 2A). This was accompanied by reduction in ROS (Figure 2B). The same phenomenon occurred in p47phox of both untreated and oxLDL-treated RAW264.7 cells (Figure 2C). These results suggest that caveolin-1 may signal to increase the protein levels of p47phox, creating a chain reaction to promote oxidative responses.
oxLDL leads to cellular ageing
Both oxLDL and caveolin-1 have been implicated in atherosclerotic and inflammation changes. To study whether oxLDL’s effect requires caveolin-1, we treated RAW264.7 cells with oxLDL and their matrix metalloproteinase MMP2 and MMP9 levels were studied [16,19]. At both 60 and 80 μg/ml, oxLDL promoted significant increase in MMP9 and MMP2, indicating a positive effect on inflammation (Figure 3A). While caveolin-1 shRNA did not completely block MMP9 production, the overall levels were proportionally reduced. MMP2 on the other hand, completely disappeared. In support of the involvement of caveolin-1 in senescence, β-gal production [20] upon oxLDL treatment was also significantly blocked by the caveolin-1 knockdown, confirming that the ability of oxLDL to induce cellular ageing requires caveolin-1 (Figure 3B).
oxLDL promotes caveolin-1 and p47phox membrane colocalization
NADPH oxidase is only functional in its membrane-associated forms [21,22]. In oxLDL-mediated activation, caveolin-1 is increased at the protein level (Figure 1). Currently, there is no knowledge whether caveolin-1 and p47phox can directly regulate each other. Should this be the case, it would suggest that p47phox is recruited to the membrane via caveolin-1, providing the necessary membrane targetting for its activation. Upon oxLDL stimulation, p47phox became associated with caveolin-1, as revealed by immunoprecipitation (Figure 4A). This result indicates caveolin-1 may serve as the ‘membrane address’ or a target for the membrane recruitment of p47phox. For visualization, we co-stained caveolin-1 and p47phox before and after oxLDL treatment. Before the treatment, both molecules appeared in diffused fashion. However, oxLDL led to a dramatic co-localization on the membrane (Figure 4B). Therefore, our results suggest that one of the effects of oxLDL is to regulate the association between caveolin-1 and p47phox, potentially initiating ROS production.
Discussion
NADPH oxidases are a vital contributor to the ROS generation which plays an essential role in cellular senescence. As NOXs are functionally gated by the membrane recruitment, the regulatory events in this process are important study topics. On the other hand, genetic deletion of Caveolin-1 is associated with a significant increase in serum cholesterol levels and a significantly reduced rate of atherosclerosis [23]. A more precise model employing the overexpression of caveolin-1 in endothelium further confirmed its role in the disease [24]. These findings confirm the role of caveolin-1 in transcytosis of cholesterol into the subendothelial space. Yet, whether these two seemingly independent factors may function co-operatively is currently unknown. This work reveals a direct association between p47phox and caveolin-1, suggesting a new regulatory event in the pro-atherosclerotic activities of NOXs and caveolae.
As oxLDL requires caveolae for this internalization, the binding of oxLDL will likely to change the latter’s state of association with other signaling/structural moieties. In hepatocytes, TGF-β activates NOX1 in a Caveolin-1-dependent manner [25]. In that particular report, the association of src family kinases to the CSD is likely the molecular link leading to NOX1 activation. Whether such a similar process is at work for NOX2 is not known. Prior to this work, it was found by confocal imaging in THP-1 cells that p47phox showed increased membrane recruitment and caveolin-1 association following high glucose treatment [26]. A detailed fractionation study suggested that in the membrane highly enriched with caveolin-1 there is significant presence of actin cytoskeleton [27]. In another report, the actin cytoskeleton shows strong association with p40phox and p47phox subunits, and this association is a regulatory mechanism for neuronal NOX2 activities [28]. These observations may suggest a bridging mechanism for targetting p47phox to the membrane, i.e. via cortical cytoskeleton. On the other hand, as caveolae are a subset of the generically defined lipid rafts [21], and the lipid rafts have the natural tendency to gather PIP2 [29]. NOX may be attracted by PIP2 in the vicinity of caveolae. In a sophisticated analysis, a previous report demonstrated that p47phox is uniquely attracted via electrostatic interactions and used its PX domain to insert hydrophobic residues into the membrane [30]. In spite of these indirect associations, in this work we were able to show a direct association of these two proteins, as analyzed by co-immunoprecipitation, suggesting a direct molecular association and further confirming the results by Hayashi et al. [26]. Further understanding the molecular details of this association may require detailed mutational mapping of both molecules. Nevertheless, previous reports and our current analysis suggest several possible routes whereby p47phox is targetted to the membrane, which serves as a promising target for therapeutic intervention.
Acknowledgments
We thank Dr Yan Shi (Department of Basic Medical Sciences, School of Medicine, Tsinghua-Peking Joint Center for Life Sciences, Tsinghua University) for the help of this research.
Abbreviations
- β-gal
β-galactosidase
- CSD
caveolin scaffolding domain
- GAPDH
glyceraldehyde phosphate dehydrogenase
- MAPK
mitogen-activated protein kinase
- oxLD
oxidative low density lipoprotein
- ROS
reactive oxygen species
Competing interests
The authors declare that there are no competing interests associated with the manuscript.
Funding
This work was supported by the National Natural Science Foundation of China [grant number 81501195].
Author contribution
J.W. performed the experiments, data analyses, and wrote the original draft. Y.B. cultured the cells and performed part of the experiments. X.Z. constructed the viral vector and performed data analysis. J.R. and N.K. interpreted the results and supervised the experiments.T.T. and L.T. provided suggestions for revision.Y.A. contibuted to cell culture procedure. P.L. provided overall design, critical review of the manuscript and acquired the funding.
References
- 1.Wang J.C. and Bennett M. (2012) Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ. Res. 111, 245–259 10.1161/CIRCRESAHA.111.261388 [DOI] [PubMed] [Google Scholar]
- 2.Konior A., Schramm A., Czesnikiewicz-Guzik M. and Guzik T.J. (2014) NADPH oxidases in vascular pathology. Antioxid. Redox Signal. 20, 2794–2814 10.1089/ars.2013.5607 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Manea A. (2010) NADPH oxidase-derived reactive oxygen species: involvement in vascular physiology and pathology. Cell Tissue Res. 342, 325–339 10.1007/s00441-010-1060-y [DOI] [PubMed] [Google Scholar]
- 4.Rivera J., Sobey C.G., Walduck A.K. and Drummond G.R. (2010) Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models. Redox Rep. 15, 50–63 10.1179/174329210X12650506623401 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.El-Benna J., Dang P.M., Gougerot-Pocidalo M.A., Marie J.C. and Braut-Boucher F. (2009) p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases. Exp. Mol. Med. 41, 217–225 10.3858/emm.2009.41.4.058 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Frank P.G. (2010) Endothelial caveolae and caveolin-1 as key regulators of atherosclerosis. Am. J. Pathol. 177, 544–546 10.2353/ajpath.2010.100247 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Chanvorachote P. and Chunhacha P. (2013) Caveolin-1 regulates endothelial adhesion of lung cancer cells via reactive oxygen species-dependent mechanism. PLoS ONE 8, e57466 10.1371/journal.pone.0057466 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Cho K.A. and Park S.C. (2005) Caveolin-1 as a prime modulator of aging: a new modality for phenotypic restoration? Mech. Ageing Dev. 126, 105–110 10.1016/j.mad.2004.09.029 [DOI] [PubMed] [Google Scholar]
- 9.Anderson R.G.W. and Jacobson K. (2002) Cell biology - A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains. Science 296, 1821–1825 10.1126/science.1068886 [DOI] [PubMed] [Google Scholar]
- 10.Kiss A.L. and Botos E. (2009) Endocytosis via caveolae: alternative pathway with distinct cellular compartments to avoid lysosomal degradation? J. Cell. Mol. Med. 13, 1228–1237 10.1111/j.1582-4934.2009.00754.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Frank P.G. and Lisanti M.P. (2004) Caveolin-1 and caveolae in atherosclerosis: differential roles in fatty streak formation and neointimal hyperplasia. Curr. Opin. Lipidol. 15, 523–529 10.1097/00041433-200410000-00005 [DOI] [PubMed] [Google Scholar]
- 12.Pavlides S., Gutierrez-Pajares J.L., Danilo C., Lisanti M.P. and Frank P.G. (2012) Atherosclerosis, caveolae and caveolin-1, caveolins and caveolae: roles in signaling and disease mechanisms. 729, 127–144 [DOI] [PubMed] [Google Scholar]
- 13.Qin L., Zhu N., Ao B.X., Liu C., Shi Y.N., Du K. et al. (2016) Caveolae and caveolin-1 integrate reverse cholesterol transport and inflammation in atherosclerosis. Int. J. Mol. Sci. 17, 10.3390/ijms17030429 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Cohen A.W., Hnasko R., Schubert W. and Lisanti M.P. (2004) Role of caveolae and caveolins in health and disease. Physiol. Rev. 84, 1341–1379 10.1152/physrev.00046.2003 [DOI] [PubMed] [Google Scholar]
- 15.Liu P., Ying Y. and Anderson R.G. (1997) Platelet-derived growth factor activates mitogen-activated protein kinase in isolated caveolae. Proc. Natl. Acad. Sci. U.S.A. 94, 13666–13670 10.1073/pnas.94.25.13666 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Williams T.M., Medina F., Badano I., Hazan R.B., Hutchinson J., Muller W.J. et al. (2004) Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo - Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J. Biol. Chem. 279, 51630–51646 10.1074/jbc.M409214200 [DOI] [PubMed] [Google Scholar]
- 17.Zhu X.Y., Li P., Yang Y.B. and Liu M.L. (2013) Xuezhikang, extract of red yeast rice, improved abnormal hemorheology, suppressed caveolin-1 and increased eNOS expression in atherosclerotic rats. PLoS ONE 8, 10.1371/journal.pone.0062731 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Wu C.C., Wang S.H., Kuan II, Tseng W.K., Chen M.F., Wu J.C. et al. (2009) OxLDL upregulates caveolin-1 expression in macrophages: Role for caveolin-1 in the adhesion of oxLDL-treated macrophages to endothelium. J. Cell Biochem. 107, 460–472 10.1002/jcb.22144 [DOI] [PubMed] [Google Scholar]
- 19.Yu T.Y., Pang J.H., Wu K.P., Chen M.J., Chen C.H. and Tsai W.C. (2013) Aging is associated with increased activities of matrix metalloproteinase-2 and -9 in tenocytes. BMC Musculoskelet. Disord. 14, 2 10.1186/1471-2474-14-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Lee B.Y., Han J.A., Im J.S., Morrone A., Johung K., Goodwin E.C. et al. (2006) Senescence-associated beta-galactosidase is lysosomal beta-galactosidase. Aging Cell 5, 187–195 10.1111/j.1474-9726.2006.00199.x [DOI] [PubMed] [Google Scholar]
- 21.Patel H.H. and Insel P.A. (2009) Lipid rafts and caveolae and their role in compartmentation of redox signaling. Antioxid. Redox Signal. 11, 1357–1372 10.1089/ars.2008.2365 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Panday A., Sahoo M.K., Osorio D. and Batra S. (2015) NADPH oxidases: an overview from structure to innate immunity-associated pathologies. Cell Mol. Immunol. 12, 5–23 10.1038/cmi.2014.89 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Frank P.G., Lee H., Park D.S., Tandon N.N., Scherer P.E. and Lisanti M.P. (2004) Genetic ablation of caveolin-1 confers protection against atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24, 98–105 10.1161/01.ATV.0000101182.89118.E5 [DOI] [PubMed] [Google Scholar]
- 24.Fernandez-Hernando C., Yu J., Davalos A., Prendergast J. and Sessa W.C. (2010) Endothelial-specific overexpression of caveolin-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Am. J. Pathol. 177, 998–1003 10.2353/ajpath.2010.091287 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Moreno-Caceres J., Mainez J., Mayoral R., Martin-Sanz P., Egea G. and Fabregat I. (2016) Caveolin-1-dependent activation of the metalloprotease TACE/ADAM17 by TGF-beta in hepatocytes requires activation of Src and the NADPH oxidase NOX1. FEBS J. 283, 1300–1310 10.1111/febs.13669 [DOI] [PubMed] [Google Scholar]
- 26.Hayashi T., Juliet P.A., Miyazaki A., Ignarro L.J. and Iguchi A. (2007) High glucose downregulates the number of caveolae in monocytes through oxidative str ess from NADPH oxidase: implications for atherosclerosis. Biochim. Biophys. Acta 1772, 364–372 10.1016/j.bbadis.2006.11.011 [DOI] [PubMed] [Google Scholar]
- 27.Lisanti M.P., Scherer P.E., Vidugiriene J., Tang Z., Hermanowski-Vosatka A., Tu Y.H. et al. (1994) Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J. Cell Biol. 126, 111–126 10.1083/jcb.126.1.111 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Munnamalai V., Weaver C.J., Weisheit C.E., Venkatraman P., Agim Z.S., Quinn M.T. et al. (2014) Bidirectional interactions between NOX2-type NADPH oxidase and the F-actin cytoskeleton in neuronal growth cones. J. Neurochem. 130, 526–540 10.1111/jnc.12734 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Koldso H., Shorthouse D., Helie J. and Sansom M.S. (2014) Lipid clustering correlates with membrane curvature as revealed by molecular simulations of complex lipid bilayers. PLoS Comput. Biol. 10, e1003911 10.1371/journal.pcbi.1003911 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Stahelin R.V., Burian A., Bruzik K.S., Murray D. and Cho W. (2003) Membrane binding mechanisms of the PX domains of NADPH oxidase p40phox and p47phox. J. Biol. Chem. 278, 14469–14479 10.1074/jbc.M212579200 [DOI] [PubMed] [Google Scholar]